CheckMate -214 Study Reveals Which Patients with Advanced Kidney Cancer Benefit from Nivolumab + Ipilimumab Combination

CheckMate -214 Study Reveals Which Patients with Advanced Kidney Cancer Benefit from Nivolumab + Ipilimumab Combination

Annual-Meeting

1 year
252 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Saby George, MD, FACP, Roswell Park Cancer Institute, shares Checkmate-214 Not for All Kidney Cancer Patients | Study for Advanced Metastatic Kidney Cancer at Annual Meeting 2018
Up Next Autoplay